SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-000517
Filing Date
2023-01-04
Accepted
2023-01-04 07:24:13
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5423
  Complete submission text file 0001209191-23-000517.txt   7012
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS THIRD FLOOR NEW YORK NY 10036
Business Address
Rabinowitz Michael (Reporting) CIK: 0001876182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 23504351